BJBluejay Diagnostics, Inc. BJDX · NASDAQ
$0.63 -6.94% (-$0.05)
- Market cap
- $720.6K
- Enterprise value
- -$8.80M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- -
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -77.6%
- Gross margin
- -
- Net margin
- -
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 0.89
- Free float
- 85.0%
About the company
Bluejay Diagnostics, Inc. (BJDX) is a company focused on diagnostic technologies and innovative medical tests. Its products and technologies are geared towards early detection and diagnosis of various diseases and health conditions. Bluejay Diagnostics aims to develop accurate, fast, and user-friendly diagnostic tests that can be used in hospitals, clinics, laboratories, and even at home by patients. The company emphasizes innovation and research to provide healthcare professionals and patients with reliable and effective tools for diagnosing and treating various diseases. Bluejay Diagnostics aims to contribute to improving the health status and quality of life of patients. Shares of Bluejay Diagnostics, Inc. (BJDX) can represent an interesting investment opportunity for those who believe in the growth potential of diagnostic technologies and the innovative healthcare industry.
Sector
Healthcare
Industry
Medical - Devices
CEO
Indranil Dey
Employees
6
Headquarters
Acton
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number